143 related articles for article (PubMed ID: 17010057)
1. An update on raloxifene.
Draper MW
Int J Gynecol Cancer; 2006; 16 Suppl 2():502-3. PubMed ID: 17010057
[No Abstract] [Full Text] [Related]
2. Raloxifene and endometrial cancer.
Sismondi P; Biglia N; Ujcic E; Ponzone R; Roagna R
Tumori; 2001; 87(5):S18-9. PubMed ID: 11765199
[No Abstract] [Full Text] [Related]
3. Update on raloxifene to prevent endometrial-breast cancer.
Goldstein SR
Eur J Cancer; 2000 Sep; 36 Suppl 4():S54-6. PubMed ID: 11056320
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene for breast cancer prevention.
Plouffe L
JAMA; 2001 Apr; 285(16):2079. PubMed ID: 11311092
[No Abstract] [Full Text] [Related]
5. Raloxifene: risks and benefits.
Barrett-Connor E
Ann N Y Acad Sci; 2001 Dec; 949():295-303. PubMed ID: 11795366
[TBL] [Abstract][Full Text] [Related]
6. An update on breast cancer prevention trials.
Wickerham DL; Fourchotte V
Int J Gynecol Cancer; 2006; 16 Suppl 2():498-501. PubMed ID: 17010056
[TBL] [Abstract][Full Text] [Related]
7. NCI and the STELLAR trial.
The Lancet
Lancet; 2007 Jun; 369(9580):2134. PubMed ID: 17604779
[No Abstract] [Full Text] [Related]
8. Selective estrogen receptor modulators and prevention of invasive breast cancer.
Gradishar WJ; Cella D
JAMA; 2006 Jun; 295(23):2784-6. PubMed ID: 16754726
[No Abstract] [Full Text] [Related]
9. Update in general internal medicine.
Mincey BA
Ann Intern Med; 2001 Aug; 135(4):300-1. PubMed ID: 11511149
[No Abstract] [Full Text] [Related]
10. [What do we think about selective estrogen receptor modulators?].
Cortet B
Rev Med Interne; 2001 Dec; 22(12):1173-6. PubMed ID: 11794886
[No Abstract] [Full Text] [Related]
11. Chemoprevention of breast cancer.
Zelnak AB; O'Regan RM
Curr Probl Cancer; 2004; 28(4):201-17. PubMed ID: 15318323
[No Abstract] [Full Text] [Related]
12. CORE breast-cancer prevention trial.
Bradbury J
Lancet Oncol; 2005 Jan; 6(1):8. PubMed ID: 15672490
[No Abstract] [Full Text] [Related]
13. Raloxifene vs tamoxifen.
Goldstein SR
JAMA; 2007 Jan; 297(3):263-4; author reply 264. PubMed ID: 17227974
[No Abstract] [Full Text] [Related]
14. [Molecular mechanism tissue-specific actions of selective estrogen receptor modulators].
Urano T
Nihon Ronen Igakkai Zasshi; 2006 Mar; 43(2):147-51. PubMed ID: 16683636
[No Abstract] [Full Text] [Related]
15. Selective oestrogen receptor modulation: molecular pharmacology for the millennium.
Levenson AS; Jordan VC
Eur J Cancer; 1999 Dec; 35(14):1974-85. PubMed ID: 10711240
[TBL] [Abstract][Full Text] [Related]
16. STAR: first-year recruitment efforts set brisk pace for future.
CA Cancer J Clin; 2000; 50(5):271-2. PubMed ID: 11075236
[No Abstract] [Full Text] [Related]
17. Breast cancer prevention.
Rodabaugh KJ; Bloss JD
Clin Obstet Gynecol; 2001 Sep; 44(3):478-84. PubMed ID: 11685873
[No Abstract] [Full Text] [Related]
18. Raloxifene examined for breast cancer prevention.
Young D
Am J Health Syst Pharm; 2007 Sep; 64(17):1774. PubMed ID: 17724350
[No Abstract] [Full Text] [Related]
19. Measurement of serum estradiol.
McKiernan F; Wiley C
JAMA; 2002 Mar; 287(12):1528. PubMed ID: 11911752
[No Abstract] [Full Text] [Related]
20. Beyond raloxifene for the prevention of osteoporosis and breast cancer.
Jordan VC
Br J Pharmacol; 2007 Jan; 150(1):3-4. PubMed ID: 17115068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
